Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery

被引:21
|
作者
Pan, Shu-Ting [1 ]
Xue, Danfeng [1 ]
Li, Zhi-Ling [2 ]
Zhou, Zhi-Wei [3 ]
He, Zhi-Xu [4 ,5 ]
Yang, Yinxue [6 ]
Yang, Tianxin [7 ,8 ]
Qiu, Jia-Xuan [1 ]
Zhou, Shu-Feng [9 ]
机构
[1] Nanchang Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, Nanchang 330003, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Pharm, Shanghai 200040, Peoples R China
[3] Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Amarillo, TX 79106 USA
[4] Guizhou Med Univ, Stem Cell & Tissue Engn Res Ctr, Guizhou Prov Key Lab Regenerat Med, Guiyang 550004, Peoples R China
[5] Guizhou Med Univ, Sino US Joint Lab Med Sci, Guiyang 550004, Peoples R China
[6] Ningxia Med Univ, Gen Hosp, Dept Colorectal Surg, Yinchuan 750004, Peoples R China
[7] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA
[8] Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT 84132 USA
[9] Huaqiao Univ, Coll Chem Engn, Dept Chem & Pharmaceut Engn, Xiamen 361021, Fujian, Peoples R China
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2016年 / 17卷 / 07期
关键词
human CYP; drug metabolism; paralog; homolog; ortholog; comparative genomics; bioinformatics; FUNCTIONAL ANNOTATION; MOLECULAR EVOLUTION; GENE-FUNCTION; ENZYMES; MOUSE; DUPLICATION; PSEUDOGENES; SUBFAMILY; SEQUENCE; ORGANIZATION;
D O I
10.3390/ijms17071020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human cytochrome P450 (CYP) superfamily consisting of 57 functional genes is the most important group of Phase I drug metabolizing enzymes that oxidize a large number of xenobiotics and endogenous compounds, including therapeutic drugs and environmental toxicants. The CYP superfamily has been shown to expand itself through gene duplication, and some of them become pseudogenes due to gene mutations. Orthologs and paralogs are homologous genes resulting from speciation or duplication, respectively. To explore the evolutionary and functional relationships of human CYPs, we conducted this bioinformatic study to identify their corresponding paralogs, homologs, and orthologs. The functional implications and implications in drug discovery and evolutionary biology were then discussed. GeneCards and Ensembl were used to identify the paralogs of human CYPs. We have used a panel of online databases to identify the orthologs of human CYP genes: NCBI, Ensembl Compara, GeneCards, OMA (Orthologous MAtrix) Browser, PATHER, TreeFam, EggNOG, and Roundup. The results show that each human CYP has various numbers of paralogs and orthologs using GeneCards and Ensembl. For example, the paralogs of CYP2A6 include CYP2A7, 2A13, 2B6, 2C8, 2C9, 2C18, 2C19, 2D6, 2E1, 2F1, 2J2, 2R1, 2S1, 2U1, and 2W1; CYP11A1 has 6 paralogs including CYP11B1, 11B2, 24A1, 27A1, 27B1, and 27C1; CYP51A1 has only three paralogs: CYP26A1, 26B1, and 26C1; while CYP20A1 has no paralog. The majority of human CYPs are well conserved from plants, amphibians, fishes, or mammals to humans due to their important functions in physiology and xenobiotic disposition. The data from different approaches are also cross-validated and validated when experimental data are available. These findings facilitate our understanding of the evolutionary relationships and functional implications of the human CYP superfamily in drug discovery.
引用
收藏
页数:43
相关论文
共 50 条
  • [21] Computational Prediction of Inhibitors and Inducers of the Major Isoforms of Cytochrome P450
    Rudik, Anastassia
    Dmitriev, Alexander
    Lagunin, Alexey
    Filimonov, Dmitry
    Poroikov, Vladimir
    MOLECULES, 2022, 27 (18):
  • [22] Identification and characterization of a bacterial cytochrome P450 for the metabolism of diclofenac
    Prior, Jamie E.
    Shokati, Touraj
    Christians, Uwe
    Gill, Ryan T.
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2010, 85 (03) : 625 - 633
  • [23] Application of semi-automated metabolite identification software in the drug discovery process for rapid identification of metabolites and the cytochrome P450 enzymes responsible for their formation
    Ramanathan, R
    McKenzie, DL
    Tugnait, M
    Siebenaler, K
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (05) : 945 - 951
  • [24] Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate
    Dangi, Bikash
    Davydova, Nadezhda Y.
    Vavilov, Nikita E.
    Zgoda, Victor G.
    Davydov, Dmitri R.
    XENOBIOTICA, 2020, 50 (12) : 1393 - 1405
  • [25] Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily
    Yoshida, Y
    Aoyama, Y
    Noshiro, M
    Gotoh, O
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) : 799 - 804
  • [26] The human drug metabolizing cytochromes P450
    Wrighton, SA
    VandenBranden, M
    Ring, BJ
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (05): : 461 - 473
  • [27] High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli
    Iwata, H
    Fujita, K
    Kushida, H
    Suzuki, A
    Konno, Y
    Nakamura, K
    Fujino, A
    Kamataki, T
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) : 1315 - 1325
  • [28] Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3
    Kim, Dong-Hyun
    Kim, Keon-Hee
    Kim, Dooil
    Jung, Heung-Chae
    Pan, Jae-Gu
    Chi, Youn-Tai
    Ahn, Taeho
    Yun, Chul-Ho
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 63 (3-4) : 179 - 187
  • [29] Potential inhibition of major human cytochrome P450 isoenzymes by selected tropical medicinal herbs-Implication for herb-drug interactions
    Showande, Segun Johnson
    Fakeye, Titilayo Oyelola
    Kajula, Marena
    Hokkanen, Juho
    Tolonen, Ari
    FOOD SCIENCE & NUTRITION, 2019, 7 (01): : 44 - 55
  • [30] Identification and in silico prediction of metabolites of tebufenozide derivatives by major human cytochrome P450 isoforms
    Edamatsu, Hiroaki
    Yagawa, Masataka
    Ikushiro, Shinichi
    Sakaki, Toshiyuki
    Nakagawa, Yoshiaki
    Miyagawa, Hisashi
    Akamatsu, Miki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (09)